Disease Registry based approaches to determining molecular risk factors for glaucoma blindness, and applying them in clinical practice

执业研究员汇集了来自澳大利亚，新西兰和现在国际上因青光眼和糖尿病并发症而失明的患者的大量人群，以确定促成因素。他已经成功地确定了这些疾病的主要临床和遗传风险因素，现在正在将这些知识应用于疾病早期阶段的患者，以便更早和更积极地治疗高风险个体，从而改善预后。

The Practitioner-Fellow has drawn together very large cohorts of patients from Australia, New Zealand and now internationally who have lost vision from Glaucoma and complications of Diabetes to determine the contributing factors. He has successfully identified major clinical and genetic risk factors for these diseases, and is now applying the knowledge to patients in early stages of disease, so that earlier and more aggressive treatment high risk individuals can lead to improved outcomes.